The size of the Hyaluronic Acid Products Market in Europe was around USD 2202.89 Million in 2021. It is expected to grow at a CAGR of 8.57% to reach USD 3323.08 million by 2026.
The hyaluronic acid products market in the European region has found various increasing applications in the past several decades, such as in cosmetics such as dermal fillers, for the treatment of rheumatoid arthritis, osteoporosis, hyperpigmentation, in composition for several cosmetic crèmes and gels, etc. The hyaluronic has also found uses in aesthetic surgeries like removal, Botox, burns, ophthalmic reflux, etc. The adoption of hyaluronic acid in the cosmetics industry has increased owing to several advantages with its moisturizing properties for healthy skin. Furthermore, for the treatment of osteoarthritis, the joint is injected with hyaluronic acid to aid in the repair and act as a shock absorber. The long-term effects are one of the primary key factors attracting consumers to this material and driving the market growth.
Hyaluronic acid has been found to increase adoption for joint disorders caused due to rising rates of obesity, osteoarthritis, and joint pain. In addition, synovitis has fueled the demand for hyaluronic acid injections as a treatment. The cosmetics industry in Europe is evolving at a high rate in terms of product availability and innovations. In addition, skin-related products are becoming increasingly popular amongst the younger for glowing skin and older age group for anti-aging akin features. Moreover, rapid and continuous research and development would open up new areas and drive the market growth during the forecast period.
However, the lack of awareness of hyaluronic acid is limited because the material can be harmful to the skin and surrounding structures when used in higher quantities. Due to this factor, there are stringent rules for the product approval and launch into the market. This is one of the significant restraints faced by the European hyaluronic acid market. Nevertheless, these products have lesser side effects when used in moderation. Moreover, the production of hyaluronic acid is complex, resulting in higher manufacturing costs and expensive skincare procedures that are anticipated to impact the market during the forecast period negatively.
This research report on the European hyaluronic acid products market has been segmented and sub-segmented into the following categories:
By Product Type:
By Application:
By Country:
Geographically, the UK is the leading market for hyaluronic acid products in Europe. In 2019, the market accounted for nearly 38% of the overall market share region-wise. According to Eurostat, the adjusted gross household disposable income per capita in Europe was around $ 22,999 in 2018, up from nearly $ 20,555 in 2013. The high proportion of the middle-aged population in the region is also one of the main factors for the market's growth. According to the United Nations, around 46% of the total population in Europe is in the 35 to 65 age group in 2019. Although the middle age group is the primary consumer of derma fillers and cosmetic products, the market growth is driven by the popularity of derma filler, awareness about osteoarthritis, and high healthcare expenditure in the region.
The German market is expected to experience a promising CAGR in the European market during the forecast period. It is the country's largest economy and one of the top destinations for dermal fillers globally, mainly due to medical tourism and the availability of high-end products in the region. Dermatologists inject hyaluronic acid-based fillers to firm/volumize the skin. Women especially undergo these surgeries to improve their appearance. The use of hyaluronic acid in the cosmetic industry is increasing due to the growing concern about aging skin, the desire to look young, and other skin issues. The different types of surgeries to help give a youthful look are facelift, skin resurfacing, etc. These factors will help raise the regional market revenues to new heights in the upcoming years.
The market growth in other European countries such as France, Spain, and Sweden, is attributed to the increase in the geriatric population, who mainly supply a large customer base for anti-age.
KEY MARKET PLAYERS:
A few of the promising companies operating in the European hyaluronic acid products market profiled in this report are Allergan, Sanofi, Ferring B.V., Zimmer Biomet, Fidia Farmceutici, Salix Pharmaceutical, Anika Therapeutics, Seikagaku Corporation, Hoffmann-LA Roche Ltd, Alcon, Inc., Smith & Nephew plc and F.Merz Asthetics, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Single Cycle Injection Products
5.1.3 Three Cycle Injectin Products
5.1.4 Five cycle injection Products
5.1.5 Y-o-Y Growth Analysis, By Product Type
5.1.6 Market Attractiveness Analysis, By Product Type
5.1.7 Market Share Analysis, By Product Type
5.2 Application
5.2.1 Introduction
5.2.2 Osteoarthritis
5.2.3 Ophthalmic
5.2.4 Dermal Filler
5.2.5 Vesicoureteral Reflux
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Home
5.3.4 Clinics
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product Type
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product Type
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product Type
6.1.5.3 By Application
6.1.5.4 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Zimmer Biomet
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 StemCells
8.3 Allergan
8.4 Sanofi
8.5 Ferring B.V
8.6 Fidia Farmceutici
8.7 Salix Pharmaceutical
8.8 Anika Therpeutics
8.9 Seikagaku Corporation
8.10 Hoffmann-LA Roche Ltd
8.11 Smith & nephew plc.
8.12 F.Merz Asthetics, inc
8.13 Alcon
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
